Insights into the pathogenesis and genetic background of patency of the ductus arteriosus

Neonatology

Volumn 98, Issue 1, 2010, Pages 6-17

  Bökenkamp, Regina ^a   Deruiter, Marco C ^a   Van Munsteren, Conny ^a   Gittenberger De Groot, Adriana C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Ductus arteriosus; Ductus arteriosus regulation, animal models; Ductus arteriosus remodeling, animal models; Persistent ductus arteriosus, syndromic non syndromic; Vascular smooth muscle cells

Indexed keywords

ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; BRADYKININ; CALCIUM CHANNEL L TYPE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1; INDOMETACIN; MYOCARDIN; MYOSIN HEAVY CHAIN; NITRIC OXIDE; OXYGEN; PLATELET DERIVED GROWTH FACTOR BB; POTASSIUM CHANNEL KV1.5; POTASSIUM CHANNEL KV2 1; PROSTACYCLIN SYNTHASE; PROSTAGLANDIN E2; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR AP 2 BETA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1; UNCLASSIFIED DRUG; VASCULOTROPIN; VOLTAGE GATED POTASSIUM CHANNEL; TFAP2B PROTEIN, HUMAN;

ACTA 2 GENE; ARTERY MEDIA; CELL DIFFERENTIATION; CHILD; DEVELOPMENTAL GENETICS; DUCTUS ARTERIOSUS OBLITERATION; FETUS DEVELOPMENT; GENE; GENE MUTATION; GENE TRANSFER; GENETIC PREDISPOSITION; HUMAN; MYH 11 GENE; MYOCARDIN GENE; NONHUMAN; PATENT DUCTUS ARTERIOSUS; PATHOGENESIS; PERINATAL DEVELOPMENT; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SMOOTH MUSCLE FIBER; TFAP 2B GENE; VASCULAR SMOOTH MUSCLE; ANIMAL; DISEASE MODEL; DOG; DUCTUS ARTERIOSUS, PATENT; GENETICS; GROWTH, DEVELOPMENT AND AGING; MOUSE; MUTATION; NEWBORN; PREMATURITY; RABBIT; RAT;

ANIMALS; DISEASE MODELS, ANIMAL; DOGS; DUCTUS ARTERIOSUS, PATENT; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MICE; MUSCLE, SMOOTH, VASCULAR; MUTATION; RABBITS; RATS; TRANSCRIPTION FACTOR AP-2;

ANIMALIA;

EID: 70849126297     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000262481     Document Type: Review

References (101)

1. Morris CD: Epidemiology of congenital heart disease; in Crawford MH, Di Marco JP (eds): Cardiology. London, Mosby, 2001, chapt 7, pp 1.1-1.8.
2. Gittenberger-de Groot AC: Persistent ductus arteriosus: most probably a primary congenital malformation. Br Heart J 1977; 39: 610-618.
3. Chuaqui B, Piwonka G, Farrú O: The wall in persistent ductus arteriosus (in German). Virchows Arch A Pathol Anat Histol 1977; 372: 315-324.
4. Reller MD, Rice MJ, McDonald RW: Review of studies evaluating ductal patency in the premature infant. J Pediatr 1993; 122:S59-S62.
5. Lim MK, Hanretty K, Houston AB, Lilley S, Murtagh EP: Intermittent ductal patency in healthy newborn infants: demonstration by colour Doppler flow mapping. Arch Dis Child 1992; 67: 1217-1218.
6. Walther FJ, Benders MJ, Leighton JO: Early changes in the neonatal circulatory transition. J Pediatr 1993; 123: 625-632.
7. Ly LG, Hawes J, Whyte HE, Teixeira LS, McNamara PJ: The hemodynamically significant ductus arteriosus in critically ill full-term neonates. Two case reports? Neonatology 2007; 91: 260-265.
8. Gittenberger-de Groot AC, Strengers JL, Mentink M, Poelmann RE, Patterson DF: Histologic studies on normal and persistent ductus arteriosus in the dog. J Am Coll Cardiol 1985; 6: 394-404.
9. Bokenkamp R, Gittenberger-De Groot AC, Van Munsteren CJ, Grauss RW, Ottenkamp J, Deruiter MC: Persistent ductus arteriosus in the Brown Norway inbred rat strain. Pediatr Res 2006; 60: 407-412.
10. Lamy M, De Grouchy J, Schweisguth O: Genetic and non-genetic factors in the etiology of congenital heart disease: a study of 1188 cases. Am J Hum Genet 1957; 9: 17-41.
11. Dagle JM, Lepp NT, Cooper ME, Schaa KL, Kelsey KJ, Orr KL, Caprau D, Zimmerman CR, Steffen KM, Johnson KJ, Marazita ML, Murray JC: Determination of genetic predisposition to patent ductus arteriosus in preterm infants. Pediatrics 2009; 123: 1116-1123.
12. Bhandari V, Zhou G, Bizzarro MJ, Buhimschi C, Hussain N, Gruen JR, Zhang H: Genetic contribution to patent ductus arteriosus in the premature newborn. Pediatrics 2009; 123: 669-673.
13. Ferencz C LC, Correa-Villasenor A, Wilson PD: Patent arterial duct; in Ferencz C LC, Correa-Villasenor A, Wilson PD (eds): Genetic and Environmental Risk Factors of Major Cardiovascular Malformations: The Baltimore- Washington Infant Study 1981-1989. New York, Futura, 1997, pp 285-299.
14. Stoll C, Alembik Y, Roth MP, Dott B, De Geeter B: Risk factors in congenital heart disease. Eur J Epidemiol 1989; 5: 382-391.
15. Bergwerff M, DeRuiter MC, Gittenberger-de Groot AC: Comparative anatomy and ontogeny of the ductus arteriosus, a vascular outsider. Anat Embryol 1999; 200: 559-571.
16. Agren P, Cogolludo AL, Kessels CG, Perez- Vizcaino F, De Mey JG, Blanco CE, Villamor E: Ontogeny of chicken ductus arteriosus response to oxygen and vasoconstrictors. Am J Physiol 2007; 292:R485-R496.
17. Van der Sterren S, Agren P, Zoer B, Kessels L, Blanco CE, Villamor E: Morphological and functional alterations of the ductus arteriosus in a chicken model of hypoxia-induced fetal growth retardation. Pediatr Res 2009; 65: 279-284.
18. Agren P, van der Sterren S, Cogolludo AL, Blanco CE, Villamor E: Developmental changes in the effects of prostaglandin E 2 in the chicken ductus arteriosus. J Comp Physiol 2009; 179: 133-143.
19. Sutendra G, Michelakis ED: The chicken embryo as a model for ductus arteriosus developmental biology: cracking into new territory. Am J Physiol 2007; 292:R481-R484.
20. Rabinovitch M, Beharry S, Bothwell T, Jackowski G: Qualitative and quantitative differences in protein synthesis comparing fetal lamb ductus arteriosus endothelium and smooth muscle with cells from adjacent vascular sites. Dev Biol 1988; 130: 250-258.
21. Clyman RI, Chan CY, Mauray F, Chen YQ, Cox W, Seidner SR, Lord EM, Weiss H, Waleh N, Evans SM, Koch CJ: Permanent anatomic closure of the ductus arteriosus in newborn baboons: the roles of postnatal constriction, hypoxia, and gestation. Pediatr Res 1999; 45: 19-29.
22. Gittenberger-de Groot AC, van Ertbruggen I, Moulaert AJ, Harinck E: The ductus arteriosus in the preterm infant: histologic and clinical observations. J Pediatr 1980; 96: 88-93.
23. Clyman RI, Seidner SR, Kajino H, Roman C, Koch CJ, Ferrara N, Waleh N, Mauray F, Chen YQ, Perkett EA, Quinn T: VEGF regulates remodeling during permanent anatomic closure of the ductus arteriosus. Am J Physiol 2002; 282:R199-R206.
24. Weber SC, Rheinlaender C, Sarioglu N, Peiser C, Rudiger M, Obladen M, Koehne PS: The expression of VEGF and its receptors in the human ductus arteriosus. Pediatr Res 2008; 64: 340-345.
25. Heymann MA, Rudolph AM: Control of the ductus arteriosus. Physiol Rev 1975; 55: 62-78.
26. Coceani F, Olley PM, Bodach E: Lamb ductus arteriosus: effect of prostaglandin synthesis inhibitors on the muscle tone and the response to prostaglandin E 2 . Prostaglandins 1975; 9: 299-308.
27. Clyman RI: Mechanisms regulating the ductus arteriosus. Biol Neonate 2006; 89: 330-335.
28. Coggins KG, Latour A, Ngyuen MS, Audoly L, Coffman TM, Koller BH: Metabolism of PGE 2 by prostaglandin dehydrogenase is essential for remodeling the ductus arteriosus. Nat Med 2002; 8: 91-92.
29. Leonhardt A, Glaser A, Wegmann M, Schranz D, Seyberth H, Nusing R: Expression of prostanoid receptors in human ductus arteriosus. Br J Pharmacol 2003; 138: 655-659.
30. Rheinlaender C, Weber SC, Sarioglu N, Strauss E, Obladen M, Koehne P: Changing expression of cyclooxygenases and prostaglandin receptor EP4 during development of the human ductus arteriosus. Pediatr Res 2006; 60: 270-275.
31. Ben-David Y, Hallak M, Rotschild A, Sorokin Y, Auslender R, Abramovici H: Indomethacin and fetal ductus arteriosus: complete closure after cessation of prolonged therapeutic course. Fetal Diagn Ther 1996; 11: 341-344.
32. Hammerman C, Glaser J, Kaplan M, Schimmel MS, Ferber B, Eidelman AI: Indomethacin tocolysis increases postnatal patent ductus arteriosus severity. Pediatrics 1998; 102: E56.
33. Michelakis ED, Rebeyka I, Wu X, Nsair A, Thébaud B, Hashimoto K, Dyck JR, Haromy A, Harry G, Barr A, Archer SL: O 2 sensing in the human ductus arteriosus: regulation of voltage-gated K + channels in smooth muscle cells by a mitochondrial redox sensor. Circ Res 2002; 91: 478-486.
34. Bustamante SA, Pang Y, Romero S, Pierce MR, Voelker CA, Thompson JH, Sandoval M, Liu X, Miller MJ: Inducible nitric oxide synthase and the regulation of central vessel caliber in the fetal rat. Circulation 1996; 94: 1948-1953.
35. Baragatti B, Brizzi F, Barogi S, Laubach VE, Sodini D, Shesely EG, Regan RF, Coceani F: Interactions between NO, CO and an endothelium- derived hyperpolarizing factor in maintaining patency of the ductus arteriosus in the mouse. Br J Pharmacol 2007; 151: 54-62.
36. Momma K, Toyono M: The role of nitric oxide in dilating the fetal ductus arteriosus in rats. Pediatr Res 1999; 46: 311-315.
37. Coceani F, Barogi S, Brizzi F, Ackerley C, Seidlitz E, Kelsey L, Ballou LR, Baragatti B: Cyclooxygenase isoenzymes and patency of ductus arteriosus. Prostaglandins Leukot Essent Fatty Acids 2005; 72: 71-77.
38. Sodini D, Baragatti B, Barogi S, Laubach VE, Coceani F: Indomethacin promotes nitric oxide function in the ductus arteriosus in the mouse. Br J Pharmacol 2008; 153: 1631-1640.
39. Kajimoto H, Hashimoto K, Bonnet SN, Haromy A, Harry G, Moudgil R, Nakanishi T, Rebeyka I, Thebaud B, Michelakis ED, Archer SL: Oxygen activates the Rho/Rho-kinase pathway and induces RhoB and ROCK-1 expression in human and rabbit ductus arteriosus by increasing mitochondria-derived reactive oxygen species: a newly recognized mechanism for sustaining ductal constriction. Circulation 2007; 115: 1777-1788.
40. Archer SL, Michelakis ED, Thébaud B, Bonnet S, Moudgil R, Wu XC, Weir EK: A central role for oxygen-sensitive K + channels and mitochondria in the specialized oxygensensing system. Novartis Found Symp 2006; 272: 157-171, discussion 171-175, 214-217.
41. Tristani-Firouzi M, Reeve HL, Tolarova S, Weir EK, Archer SL: Oxygen-induced constriction of rabbit ductus arteriosus occurs via inhibition of a 4-aminopyridine-, voltage- sensitive potassium channel. J Clin Invest 1996; 98: 1959-1965.
42. Coceani F, Armstrong C, Kelsey L: Endothelin is a potent constrictor of the lamb ductus arteriosus. Can J Physiol Pharmacol 1989; 67: 902-904.
43. Coceani F, Kelsey L, Ackerley C, Rabinovitch M, Gelboin H: Cytochrome P450 during ontogenic development: occurrence in the ductus arteriosus and other tissues. Can J Physiol Pharmacol 1994; 72: 217-226.
44. Fineman JR, Takahashi Y, Roman C, Clyman RI: Endothelin-receptor blockade does not alter closure of the ductus arteriosus. Am J Physiol 1998; 275:H1620-H1626.
45. Momma K, Nakanishi T, Imamura S: Inhibition of in vivo constriction of fetal ductus arteriosus by endothelin receptor blockade in rats. Pediatr Res 2003; 53: 479-485.
46. Coceani F, Liu YA, Seidlitz E, Kelsey L, Kuwaki T, Ackerley C, Yanagisawa M: Deletion of the endothelin-A-receptor suppresses oxygen- induced constriction but not postnatal closure of the ductus arteriosus. J Cardiovasc Pharmacol 2000; 36:S75-S77.
47. Archer SL, Wu XC, Thebaud B, Moudgil R, Hashimoto K, Michelakis ED: O 2 sensing in the human ductus arteriosus: redox-sensitive K + channels are regulated by mitochondria- derived hydrogen peroxide. Biol Chem 2004; 385: 205-216.
48. Hong Z, Hong F, Olschewski A, Cabrera JA, Varghese A, Nelson DP, Weir EK: Role of store-operated calcium channels and calcium sensitization in normoxic contraction of the ductus arteriosus. Circulation 2006; 114: 1372-1379.
49. Costa M, Barogi S, Socci ND, Angeloni D, Maffei M, Baragatti B, Chiellini C, Grasso E, Coceani F: Gene expression in ductus arteriosus and aorta: comparison of birth and oxygen effects. Physiol Genomics 2006; 25: 250-262.
50. Taussig HB: World survey of the common cardiac malformations: developmental error or genetic variant? Am J Cardiol 1982; 50: 544-559.
51. Patterson DF: Epidemiologic and genetic studies of congenital heart disease in the dog. Circ Res 1968; 23: 171-202.
52. Patterson DF, Pyle RL, Buchanan JW, Trautvetter E, Abt DA: Hereditary patent ductus arteriosus and its sequelae in the dog. Circ Res 1971; 29: 1-13.
53. De Reeder EG, Gittenberger-de Groot AC, van Munsteren JC, Poelmann RE, Patterson DF, Keirse MJ: Distribution of prostacyclin synthase, 6-keto-prostaglandin F 1 , and 15- hydroxy-prostaglandin dehydrogenase in the normal and persistent ductus arteriosus of the dog. Am J Pathol 1989; 135: 881-887.
54. Behmoaras J, Osborne-Pellegrin M, Gauguier D, Jacob MP: Characteristics of the aortic elastic network and related phenotypes in seven inbred rat strains. Am J Physiol 2005; 288:H769-H777.
55. Capdeville M, Coutard M, Osborne-Pellegrin MJ: Spontaneous rupture of the internal elastic lamina in the rat: the manifestation of a genetically determined factor which may be linked to vascular fragility. Blood Vessels 1989; 26: 197-212.
56. Gittenberger-de Groot AC, DeRuiter MC, Bergwerff M, Poelmann RE: Smooth muscle cell origin and its relation to heterogeneity in development and disease. Arterioscler Thromb Vasc Biol 1999; 19: 1589-1594.
57. Hirschi KK, Majesky MW: Smooth muscle stem cells. Anat Rec A Discov Mol Cell Evol Biol 2004; 276: 22-33.
58. DeRuiter MC, Poelmann RE, VanMunsteren JC, Mironov V, Markwald RR, Gittenbergerde Groot AC: Embryonic endothelial cells transdifferentiate into mesenchymal cells expressing smooth muscle actins in vivo and in vitro. Circ Res 1997; 80: 444-451.
59. Kota L, Osborne-Pellegrin M, Schulz H, Behmoaras J, Coutard M, Gong M, Hubner N: Quantitative genetic basis of arterial phenotypes in the Brown Norway rat. Physiol Genomics 2007.
60. Baragatti B, Sodini D, Uematsu S, Coceani F: Role of microsomal prostaglandin E synthase-1 (mPGES1)-derived PGE 2 in patency of the ductus arteriosus in the mouse. Pediatr Res 2008; 64: 523-527.
61. Loftin CD, Trivedi DB, Tiano HF, Clark JA, Lee CA, Epstein JA, Morham SG, Breyer MD, Nguyen M, Hawkins BM, Goulet JL, Smithies O, Koller BH, Langenbach R: Failure of ductus arteriosus closure and remodeling in neonatal mice deficient in cyclooxygenase-1 and cyclooxygenase-2. Proc Natl Acad Sci USA 2001; 98: 1059-1064.
62. Nguyen M, Camenisch T, Snouwaert JN, Hicks E, Coffman TM, Anderson PA, Malouf NN, Koller BH: The prostaglandin receptor EP4 triggers remodelling of the cardiovascular system at birth. Nature 1997; 390: 78-81.
63. Yokoyama U, Minamisawa S, Quan H, Ghatak S, Akaike T, Segi-Nishida E, Iwasaki S, Iwamoto M, Misra S, Tamura K, Hori H, Yokota S, Toole BP, Sugimoto Y, Ishikawa Y: Chronic activation of the prostaglandin receptor EP4 promotes hyaluronan-mediated neointimal formation in the ductus arteriosus. J Clin Invest 2006; 116: 3026-3034.
64. Trivedi DB, Sugimoto Y, Loftin CD: Attenuated cyclooxygenase-2 expression contributes to patent ductus arteriosus in preterm mice. Pediatr Res 2006; 60: 669-674.
65. Yu Y, Funk CD: A novel genetic model of selective COX-2 inhibition: comparison with COX-2 null mice. Prostaglandins Other Lipid Mediat 2007; 82: 77-84.
66. Baragatti B, Brizzi F, Ackerley C, Barogi S, Ballou LR, Coceani F: Cyclooxygenase-1 and -2 in the mouse ductus arteriosus: individual activity and functional coupling with nitric oxide synthase. Br J Pharmacol 2003; 139: 1505-1515.
67. Yu Y, Fan J, Chen XS, Wang D, Klein-Szanto AJ, Campbell RL, FitzGerald GA, Funk CD: Genetic model of selective COX2 inhibition reveals novel heterodimer signaling. Nat Med 2006; 12: 699-704.
68. Segi E, Sugimoto Y, Yamasaki A, Aze Y, Oida H, Nishimura T, Murata T, Matsuoka T, Ushikubi F, Hirose M, Tanaka T, Yoshida N, Narumiya S, Ichikawa A: Patent ductus arteriosus and neonatal death in prostaglandin receptor EP4-deficient mice. Biochem Biophys Res Commun 1998; 246: 7-12.
69. Morano I, Chai GX, Baltas LG, Lamounier- Zepter V, Lutsch G, Kott M, Haase H, Bader M: Smooth-muscle contraction without smooth-muscle myosin. Nat Cell Biol 2000; 2: 371-375.
70. Moser M, Pscherer A, Roth C, Becker J, Mucher G, Zerres K, Dixkens C, Weis J, Guay-Woodford L, Buettner R, Fassler R: Enhanced apoptotic cell death of renal epithelial cells in mice lacking transcription factor AP-2. Genes Dev 1997; 11: 1938-1948.
71. Ivey KN, Sutcliffe D, Richardson J, Clyman RI, Garcia JA, Srivastava D: Transcriptional regulation during development of the ductus arteriosus. Circ Res 2008; 103: 388-395.
72. Huang J, Cheng L, Li J, Chen M, Zhou D, Lu MM, Proweller A, Epstein JA, Parmacek MS: Myocardin regulates expression of contractile genes in smooth muscle cells and is required for closure of the ductus arteriosus in mice. J Clin Invest 2008; 118: 515-525.
73. Thebaud B, Michelakis ED, Wu XC, Moudgil R, Kuzyk M, Dyck JR, Harry G, Hashimoto K, Haromy A, Rebeyka I, Archer SL: Oxygen- sensitive K v channel gene transfer confers oxygen responsiveness to preterm rabbit and remodeled human ductus arteriosus: implications for infants with patent ductus arteriosus. Circulation 2004; 110: 1372-1379.
74. Mason CA, Bigras JL, O'Blenes SB, Zhou B, McIntyre B, Nakamura N, Kaneda Y, Rabinovitch M: Gene transfer in utero biologically engineers a patent ductus arteriosus in lambs by arresting fibronectin-dependent neointimal formation. Nat Med 1999; 5: 176-182.
75. Humpl T, Zaidi SH, Coe JY, Russell J, Kaneda Y, Massaeli H, Benson LN, Rabinovitch M: Gene transfer of prostaglandin synthase maintains patency of the newborn lamb arterial duct. Pediatr Res 2005; 58: 976-980.
76. Issekutz KA, Graham JM Jr, Prasad C, Smith IM, Blake KD: An epidemiological analysis of CHARGE syndrome: preliminary results from a Canadian study. Am J Med Genet A 2005; 133A:309-317.
77. Hills C, Moller JH, Finkelstein M, Lohr J, Schimmenti L: Cri du chat syndrome and congenital heart disease: a review of previously reported cases and presentation of an additional 21 cases from the Pediatric Cardiac Care Consortium. Pediatrics 2006; 117: e924-927.
78. Marino B, Digilio MC, Toscano A, Giannotti A, Dallapiccola B: Congenital heart diseases in children with Noonan syndrome: an expanded cardiac spectrum with high prevalence of atrioventricular canal. J Pediatr 1999; 135: 703-706.
79. Sletten LJ, Pierpont ME: Variation in severity of cardiac disease in Holt-Oram syndrome. Am J Med Genet 1996; 65: 128-132.
80. Satoda M, Zhao F, Diaz GA, Burn J, Goodship J, Davidson HR, Pierpont ME, Gelb BD: Mutations in TFAP2B cause Char syndrome, a familial form of patent ductus arteriosus. Nat Genet 2000; 25: 42-46.
81. Zhao F, Weismann CG, Satoda M, Pierpont ME, Sweeney E, Thompson EM, Gelb BD: Novel TFAP2B mutations that cause Char syndrome provide a genotype-phenotype correlation. Am J Hum Genet 2001; 69: 695-703.
82. Pyeritz RE, Murphy EA, McKusick VA: Clinical variability in the Marfan syndrome( s). Birth Defects Orig Artic Ser 1979; 15: 155-178.
83. Loeys BL, Schwarze U, Holm T, Callewaert BL, Thomas GH, Pannu H, De Backer JF, Oswald GL, Symoens S, Manouvrier S, Roberts AE, Faravelli F, Greco MA, Pyeritz RE, Milewicz DM, Coucke PJ, Cameron DE, Braverman AC, Byers PH, De Paepe AM, Dietz HC: Aneurysm syndromes caused by mutations in the TGF- receptor. N Engl J Med 2006; 355: 788-798.
84. Kiel EA, Frias JL, Victorica BE: Cardiovascular manifestations in the Larsen syndrome. Pediatrics 1983; 71: 942-946.
85. Pepin M, Schwarze U, Superti-Furga A, Byers PH: Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type. N Engl J Med 2000; 342: 673-680.
86. Zhu L, Vranckx R, Khau van Kien P, Lalande A, Boisset N, Mathieu F, Wegman M, Glancy L, Gasc JM, Brunotte F, Bruneval P, Wolf JE, Michel JB, Jeunemaitre X: Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus. Nat Genet 2006; 38: 343-349.
87. Guo DC, Pannu H, Tran-Fadulu V, Papke CL, Yu RK, Avidan N, Bourgeois S, Estrera AL, Safi HJ, Sparks E, Amor D, Ades L, Mc- Connell V, Willoughby CE, Abuelo D, Willing M, Lewis RA, Kim DH, Scherer S, Tung PP, Ahn C, Buja LM, Raman CS, Shete SS, Milewicz DM: Mutations in smooth muscle -actin (ACTA2) lead to thoracic aortic aneurysms and dissections. Nat Genet 2007; 39: 1488-1493.
88. Lund JT, Jensen MB, Hjelms E: Aneurysm of the ductus arteriosus. A review of the literature and the surgical implications. Eur J Cardiothorac Surg 1991; 5: 566-570.
89. Acherman RJ, Siassi B, Wells W, Goodwin M, DeVore G, Sardesai S, Wong PC, Ebrahimi M, Pratti-Madrid G, Castillo W, Ramanathan R: Aneurysm of the ductus arteriosus: a congenital lesion. Am J Perinatol 1998; 15: 653-659.
90. Dyamenahalli U, Smallhorn JF, Geva T, Fouron JC, Cairns P, Jutras L, Hughes V, Rabinovitch M, Mason CA, Hornberger LK: Isolated ductus arteriosus aneurysm in the fetus and infant: a multi-institutional experience. J Am Coll Cardiol 2000; 36: 262-269.
91. Mielke G, Benda N: Reference ranges for two-dimensional echocardiographic examination of the fetal ductus arteriosus. Ultrasound Obstet Gynecol 2000; 15: 219-225.
92. Matt P, Habashi J, Carrel T, Cameron DE, Van Eyk JE, Dietz HC: Recent advances in understanding Marfan syndrome: should we now treat surgical patients with losartan? J Thorac Cardiovasc Surg 2008; 135: 389-394.
93. Zhou B, Coulber C, Rabinovitch M: Tissuespecific and developmental regulation of transforming growth factor-α 1 expression in fetal lamb ductus arteriosus endothelial cells. Pediatr Res 1998; 44: 865-872.
94. Tannenbaum JE, Waleh NS, Mauray F, Breuss J, Pytela R, Kramer RH, Clyman RI: Transforming growth factor-α 1 inhibits fetal lamb ductus arteriosus smooth muscle cell migration. Pediatr Res 1995; 37: 561-570.
95. Tannenbaum JE, Waleh NS, Mauray F, Gold L, Perkett EA, Clyman RI: Transforming growth factor-α protein and messenger RNA expression is increased in the closing ductus arteriosus. Pediatr Res 1996; 39: 427-434.
96. Boudreau N, Clausell N, Boyle J, Rabinovitch M: Transforming growth factor-α regulates increased ductus arteriosus endothelial glycosaminoglycan synthesis and a post-transcriptional mechanism controls increased smooth muscle fibronectin, features associated with intimal proliferation. Lab Invest 1992; 67: 350-359.
97. Qiu P, Ritchie RP, Fu Z, Cao D, Cumming J, Miano JM, Wang DZ, Li HJ, Li L: Myocardin enhances Smad3-mediated transforming growth factor-α 1 signaling in a CArG box-independent manner: Smad-binding element is an important cis element for SM22 transcription in vivo. Circ Res 2005; 97: 983-991.
98. Khau van Kien P, Mathieu F, Zhu L, Lalande A, Betard C, Lathrop M, Brunotte F, Wolf JE, Jeunemaitre X: Mapping of familial thoracic aortic aneurysm/dissection with patent ductus arteriosus to 16p12.2- p13.13. Circulation 2005; 112: 200-206.
99. Mani A, Meraji SM, Houshyar R, Radhakrishnan J, Mani A, Ahangar M, Rezaie TM, Taghavinejad MA, Broumand B, Zhao H, Nelson-Williams C, Lifton RP: Finding genetic contributions to sporadic disease: a recessive locus at 12q24 commonly contributes to patent ductus arteriosus. Proc Natl Acad Sci USA 2002; 99: 15054-15059.
100. Schulz RA, Yutzey KE: Calcineurin signaling and NFAT activation in cardiovascular and skeletal muscle development. Dev Biol 2004; 266: 1-16.
101. Iwasaki S, Minamisawa S, Yokoyama U, Akaike T, Quan H, Nagashima Y, Nishimaki S, Ishikawa Y, Yokota S: Interleukin-15 inhibits smooth muscle cell proliferation and hyaluronan production in rat ductus arteriosus. Pediatr Res 2007; 62: 392-398.